e-learning
resources
London 2016
Monday, 05.09.2016
Molecular footprints in lung cancer diagnosis and management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Discovery of new drugs in thoracic oncology
Anne-Marie Dingemans (Masstricht, Netherlands)
Source:
International Congress 2016 – Molecular footprints in lung cancer diagnosis and management
Session:
Molecular footprints in lung cancer diagnosis and management
Session type:
Symposium
Number:
1948
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Anne-Marie Dingemans (Masstricht, Netherlands). Discovery of new drugs in thoracic oncology. International Congress 2016 – Molecular footprints in lung cancer diagnosis and management
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Challenges and controversies in thoracic oncology: a new ERJ series
Source: Eur Respir J 2014; 43: 1571-1572
Year: 2014
Immunotherapy: a new standard of care in thoracic malignancies?
Source: Eur Respir J, 51 (2) 1702072; 10.1183/13993003.02072-2017
Year: 2018
Perspectives on the new drugs pipeline
Source: School Course 13
Year: 2013
Lung cancer classification and characterisation in daily practice of thoracic oncology
Source: International Congress 2014 – The more in-depth classification of lung cancer: relevance for patients and science
Year: 2014
The HERMES curriculum for thoracic oncology: the first step to a pan-European thoracic oncology exam
Source: International Congress 2014 – The importance of multidisciplinary approaches to lung cancer treatment
Year: 2014
Human translational medicine in ILD: the promise of new drugs
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
Rationale and targets of immunotherapy in thoracic malignancies
Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies?
Year: 2016
The thoracic oncology specialist: curriculum recommendations in thoracic oncology training
Source: Eur Respir J 2016; 48: 628-631
Year: 2016
Assembly 11: thoracic oncology
Source: Breathe, 14 (2) 163; 10.1183/20734735.016918
Year: 2018
Prospects for new compounds tiosemikarbazonami class to create drugs with antituberculosis activity
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
New frontiers: NIV in oncology and palliation
Source: School Course 2012 - ERS School Course on Noninvasive Positive Pressure Ventilation
Year: 2012
Multidisciplinary team management in thoracic oncology: more than just a concept?
Source: Eur Respir J 2014; 43: 1776-1786
Year: 2014
Development of a novel nano-sized carrier system for aeroseol drug delivery (EGE University translational pulmonology research group)
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
The future is here in thoracic oncologic imaging: role of radiogenomics
Source: Virtual Congress 2020 – Imaging grand round
Year: 2020
Clinical nurse specialist led image guided pleural interventions – Is it safe?
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Updates in oncology
Source: Annual Congress 2013 –Ceremony for the ERS Romain Pauwels Research Award (financially supported by GlaxoSmithKline) followed by Clinical Year in Review II
Year: 2013
Updates in oncology
Source: Eur Respir Rev 2014; 23: 69-78
Year: 2014
Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology
Source: Breathe 2016; 12: 249-255
Year: 2016
Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept